Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-15 Purchase(A) |
2025-01-17 2:30 pm |
Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director |
25,000 | $3.2599 | $81,499 | 476,897 (Direct) |
View |
| 2025-01-15 Purchase |
2025-01-17 08:03 am |
Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director |
25,000 | $3.2599 | $81,499 | 476,897 (Direct) |
View |
| 2024-12-10 Sale |
2024-12-12 6:00 pm |
Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director |
359,606 | $2.8461 | $1,023,475 | 451,897 (Direct) |
View |
| 2024-09-17 Sale |
2024-09-19 8:02 pm |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
57,969 | $4.0393 | $234,155 | 5,982,582 (Indirect Direct) |
View |
| 2024-06-20 Sale |
2024-06-21 5:59 pm |
Atea Pharmaceuticals Inc. | AVIR | Polsky Bruce Director |
17,544 | $3.4852 | $61,144 | 136,406 (Direct) |
View |
| 2024-06-05 Sale |
2024-06-07 6:34 pm |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
1,006 | $4 | $4,024 | 6,040,551 (Indirect Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 9:31 pm |
Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks |
15,843 | $3.8449 | $60,915 | 958,941 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 9:30 pm |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
56,910 | $3.845 | $218,819 | 6,836,490 (Indirect Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 9:29 pm |
Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer |
15,870 | $3.8414 | $60,963 | 301,530 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 9:26 pm |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer |
12,477 | $3.8394 | $47,904 | 207,623 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 9:25 pm |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
11,819 | $3.843 | $45,420 | 303,489 (Indirect Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 9:24 pm |
Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer |
14,029 | $3.843 | $53,913 | 354,162 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-20 Option Award |
2025-02-24 6:52 pm |
N/A 2035-02-19 |
Atea Pharmaceuticals Inc. | AVIR | Kirsch Arthur S Director |
164,800 | $0 | 164,800 (Direct) |
View |
Ownership |
2025-02-24 6:47 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Kirsch Arthur S Director |
0 | $0 | 45,710 (Direct) |
View |
| 2025-01-31 Tax Withholding |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer |
14,134 | $3.06 | 339,438 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer |
211,250 | $0 | 339,438 (Direct) |
View |
| 2025-01-31 Exercise |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer |
46,800 | $0 | 339,438 (Direct) |
View |
| 2025-01-31 Tax Withholding |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
11,517 | $3.06 | 309,472 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
141,550 | $0 | 309,472 (Direct) |
View |
| 2025-01-31 Exercise |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
33,333 | $0 | 309,472 (Direct) |
View |
| 2025-01-31 Tax Withholding |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer |
16,071 | $3.06 | 304,959 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer |
202,550 | $0 | 304,959 (Direct) |
View |
| 2025-01-31 Exercise |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer |
41,533 | $0 | 304,959 (Direct) |
View |
| 2025-01-31 Tax Withholding |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks |
16,102 | $3.06 | 972,173 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks |
210,500 | $0 | 972,173 (Direct) |
View |
| 2025-01-31 Exercise |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks |
44,367 | $0 | 972,173 (Direct) |
View |
| 2025-01-31 Tax Withholding |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
88,601 | $3.06 | 6,879,949 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
639,035 | $0 | 6,879,949 (Direct) |
View |
| 2025-01-31 Exercise |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
173,467 | $0 | 6,879,949 (Direct) |
View |
| 2025-01-31 Tax Withholding |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer |
12,062 | $3.06 | 211,561 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer |
128,100 | $0 | 211,561 (Direct) |
View |
| 2025-01-31 Exercise |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer |
33,333 | $0 | 211,561 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-21 6:12 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director |
70,800 | $0 | 70,800 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-21 6:08 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director |
70,800 | $0 | 70,800 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-21 6:06 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Adams Jerome M. Director |
70,800 | $0 | 70,800 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-21 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Lucidi Bruno Director |
70,800 | $0 | 70,800 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-21 5:59 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Polsky Bruce Director |
70,800 | $0 | 136,406 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-21 5:54 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director |
70,800 | $0 | 70,800 (Direct) |
View |
| 2024-06-16 Exercise |
2024-06-18 5:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director |
33,150 | $0 | 56,445 (Direct) |
View |
| 2024-06-16 Exercise |
2024-06-18 5:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Lucidi Bruno Director |
33,150 | $0 | 83,150 (Direct) |
View |
| 2024-06-16 Exercise |
2024-06-18 5:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director |
33,150 | $0 | 811,503 (Direct) |
View |
| 2024-06-16 Exercise |
2024-06-18 5:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Polsky Bruce Director |
33,150 | $0 | 83,150 (Direct) |
View |
| 2024-06-16 Exercise |
2024-06-18 5:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director |
33,150 | $0 | 33,150 (Direct) |
View |
| 2024-06-16 Exercise |
2024-06-18 5:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Adams Jerome M. Director |
33,150 | $0 | 33,150 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 9:31 pm |
N/A 2034-01-30 |
Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks |
200,000 | $0 | 958,941 (Direct) |
View |
| 2024-01-31 Exercise |
2024-02-02 9:31 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks |
44,367 | $0 | 958,941 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 9:30 pm |
N/A 2034-01-30 |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
448,000 | $0 | 6,836,490 (Direct) |
View |
| 2024-01-31 Exercise |
2024-02-02 9:30 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
173,467 | $0 | 6,836,490 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 9:29 pm |
N/A 2034-01-30 |
Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer |
192,800 | $0 | 301,530 (Direct) |
View |
| 2024-01-31 Exercise |
2024-02-02 9:29 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer |
41,534 | $0 | 301,530 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 9:26 pm |
N/A 2034-01-30 |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer |
120,100 | $0 | 207,623 (Direct) |
View |
| 2024-01-31 Exercise |
2024-02-02 9:26 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer |
33,334 | $0 | 207,623 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 9:25 pm |
N/A 2034-01-30 |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
132,800 | $0 | 303,489 (Direct) |
View |
| 2024-01-31 Exercise |
2024-02-02 9:25 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
33,334 | $0 | 303,489 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 9:24 pm |
N/A 2034-01-30 |
Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer |
225,200 | $0 | 354,162 (Direct) |
View |
| 2024-01-31 Exercise |
2024-02-02 9:24 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer |
46,800 | $0 | 354,162 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 4:05 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director |
79,900 | $0 | 79,900 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 4:05 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Polsky Bruce Director |
79,900 | $0 | 79,900 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 4:05 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director |
79,900 | $0 | 79,900 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 4:05 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Lucidi Bruno Director |
79,900 | $0 | 79,900 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 4:05 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Adams Jerome M. Director |
79,900 | $0 | 79,900 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 4:05 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director |
79,900 | $0 | 79,900 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 6:38 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer |
240,000 | $0 | 240,000 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 6:35 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer |
299,100 | $0 | 299,100 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 6:33 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
1,249,000 | $0 | 1,249,000 (Direct) |
View |